We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma.AuthorsFriedberg JW; Kelly JL; Neuberg D; Peterson DR; Kutok JL; Salloum R; Brenn T; Fisher DC; Ronan E; Dalton V; Rich L; Marquis D; Sims P; Rothberg PG; Liesveld J; Fisher RI; Coffman R; Mosmann T; Freedman ASPublicationBritish journal of haematology, 2009, Vol 146, Issue 3, p282ISSN1365-2141Publication typearticleDOI10.1111/j.1365-2141.2009.07773.x